Beta- and gamma-catenin expression in thyroid carcinomas

Aniello Cerrato, Francesco Fulciniti, Antonio Avallone, Giulio Benincasa, Lucio Palombini, Michele Grieco

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Cadherins are calcium-dependent cell-cell adhesion molecules whose intracellular domain forms a complex with proteins required for their function, called catenins. Down-regulation of cadherins has frequently been detected in many types of human carcinomas, being associated with tumour progression. The present study investigates the immunohistochemical expression of E-cadherin and beta- and gamma-catenin in 27 human thyroid carcinomas. E-cadherin immunoreactivity was found to be decreased at cell- cell contacts in 8/15 (53 per cent) papillary, 5/7 (71 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Beta-catenin membrane localization was found to be decreased in 6/15 (40 per cent) papillary, 2/7 (28 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Gamma-catenin expression was partially or totally lost in 13/15 (86 per cent) papillary, 6/7 (85 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. A normal pattern of expression for these three molecules was observed in areas of normal tissue in each sample. These data indicate that in addition to E-cadherin, catenins are also down-regulated at cell-cell junctions in thyroid tumours and could represent potentially useful differentiation and/or transformation markers. The high frequency of alterations of gamma-catenin expression found in thyroid carcinomas suggests an important role for this gene product in thyroid carcinogenesis.

Original languageEnglish
Pages (from-to)267-272
Number of pages6
JournalJournal of Pathology
Volume185
Issue number3
DOIs
Publication statusPublished - Jul 1998

Fingerprint

gamma Catenin
beta Catenin
Cadherins
Thyroid Neoplasms
Carcinoma
Catenins
Thyroid Gland
Intercellular Junctions
Cell Adhesion Molecules
Neoplasms
Carcinogenesis
Down-Regulation
Calcium
Membranes
Genes
Proteins

Keywords

  • Cadherin
  • Catenins
  • Immunohistochemistry
  • Thyroid carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Beta- and gamma-catenin expression in thyroid carcinomas. / Cerrato, Aniello; Fulciniti, Francesco; Avallone, Antonio; Benincasa, Giulio; Palombini, Lucio; Grieco, Michele.

In: Journal of Pathology, Vol. 185, No. 3, 07.1998, p. 267-272.

Research output: Contribution to journalArticle

Cerrato, Aniello ; Fulciniti, Francesco ; Avallone, Antonio ; Benincasa, Giulio ; Palombini, Lucio ; Grieco, Michele. / Beta- and gamma-catenin expression in thyroid carcinomas. In: Journal of Pathology. 1998 ; Vol. 185, No. 3. pp. 267-272.
@article{00ec553765b64248aefd058a436107dd,
title = "Beta- and gamma-catenin expression in thyroid carcinomas",
abstract = "Cadherins are calcium-dependent cell-cell adhesion molecules whose intracellular domain forms a complex with proteins required for their function, called catenins. Down-regulation of cadherins has frequently been detected in many types of human carcinomas, being associated with tumour progression. The present study investigates the immunohistochemical expression of E-cadherin and beta- and gamma-catenin in 27 human thyroid carcinomas. E-cadherin immunoreactivity was found to be decreased at cell- cell contacts in 8/15 (53 per cent) papillary, 5/7 (71 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Beta-catenin membrane localization was found to be decreased in 6/15 (40 per cent) papillary, 2/7 (28 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Gamma-catenin expression was partially or totally lost in 13/15 (86 per cent) papillary, 6/7 (85 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. A normal pattern of expression for these three molecules was observed in areas of normal tissue in each sample. These data indicate that in addition to E-cadherin, catenins are also down-regulated at cell-cell junctions in thyroid tumours and could represent potentially useful differentiation and/or transformation markers. The high frequency of alterations of gamma-catenin expression found in thyroid carcinomas suggests an important role for this gene product in thyroid carcinogenesis.",
keywords = "Cadherin, Catenins, Immunohistochemistry, Thyroid carcinoma",
author = "Aniello Cerrato and Francesco Fulciniti and Antonio Avallone and Giulio Benincasa and Lucio Palombini and Michele Grieco",
year = "1998",
month = "7",
doi = "10.1002/(SICI)1096-9896(199807)185:3<267::AID-PATH113>3.0.CO;2-C",
language = "English",
volume = "185",
pages = "267--272",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Beta- and gamma-catenin expression in thyroid carcinomas

AU - Cerrato, Aniello

AU - Fulciniti, Francesco

AU - Avallone, Antonio

AU - Benincasa, Giulio

AU - Palombini, Lucio

AU - Grieco, Michele

PY - 1998/7

Y1 - 1998/7

N2 - Cadherins are calcium-dependent cell-cell adhesion molecules whose intracellular domain forms a complex with proteins required for their function, called catenins. Down-regulation of cadherins has frequently been detected in many types of human carcinomas, being associated with tumour progression. The present study investigates the immunohistochemical expression of E-cadherin and beta- and gamma-catenin in 27 human thyroid carcinomas. E-cadherin immunoreactivity was found to be decreased at cell- cell contacts in 8/15 (53 per cent) papillary, 5/7 (71 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Beta-catenin membrane localization was found to be decreased in 6/15 (40 per cent) papillary, 2/7 (28 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Gamma-catenin expression was partially or totally lost in 13/15 (86 per cent) papillary, 6/7 (85 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. A normal pattern of expression for these three molecules was observed in areas of normal tissue in each sample. These data indicate that in addition to E-cadherin, catenins are also down-regulated at cell-cell junctions in thyroid tumours and could represent potentially useful differentiation and/or transformation markers. The high frequency of alterations of gamma-catenin expression found in thyroid carcinomas suggests an important role for this gene product in thyroid carcinogenesis.

AB - Cadherins are calcium-dependent cell-cell adhesion molecules whose intracellular domain forms a complex with proteins required for their function, called catenins. Down-regulation of cadherins has frequently been detected in many types of human carcinomas, being associated with tumour progression. The present study investigates the immunohistochemical expression of E-cadherin and beta- and gamma-catenin in 27 human thyroid carcinomas. E-cadherin immunoreactivity was found to be decreased at cell- cell contacts in 8/15 (53 per cent) papillary, 5/7 (71 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Beta-catenin membrane localization was found to be decreased in 6/15 (40 per cent) papillary, 2/7 (28 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. Gamma-catenin expression was partially or totally lost in 13/15 (86 per cent) papillary, 6/7 (85 per cent) follicular, and 5/5 (100 per cent) anaplastic carcinomas. A normal pattern of expression for these three molecules was observed in areas of normal tissue in each sample. These data indicate that in addition to E-cadherin, catenins are also down-regulated at cell-cell junctions in thyroid tumours and could represent potentially useful differentiation and/or transformation markers. The high frequency of alterations of gamma-catenin expression found in thyroid carcinomas suggests an important role for this gene product in thyroid carcinogenesis.

KW - Cadherin

KW - Catenins

KW - Immunohistochemistry

KW - Thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0031853107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031853107&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9896(199807)185:3<267::AID-PATH113>3.0.CO;2-C

DO - 10.1002/(SICI)1096-9896(199807)185:3<267::AID-PATH113>3.0.CO;2-C

M3 - Article

C2 - 9771480

AN - SCOPUS:0031853107

VL - 185

SP - 267

EP - 272

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -